269 related articles for article (PubMed ID: 25950691)
1. Nonsteroidal Anti-inflammatory Drugs as Prophylaxis for Heterotopic Ossification after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis.
Kan SL; Yang B; Ning GZ; Chen LX; Li YL; Gao SJ; Chen XY; Sun JC; Feng SQ
Medicine (Baltimore); 2015 May; 94(18):e828. PubMed ID: 25950691
[TBL] [Abstract][Full Text] [Related]
2. Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis.
Zhu XT; Chen L; Lin JH
Medicine (Baltimore); 2018 Aug; 97(31):e11649. PubMed ID: 30075549
[TBL] [Abstract][Full Text] [Related]
3. Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis.
Cai L; Wang Z; Luo X; She W; Zhang H
Int J Surg; 2019 Feb; 62():74-85. PubMed ID: 30615954
[TBL] [Abstract][Full Text] [Related]
4. [Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials].
Xu BG; Xue DT; Wang XH; Yan SG
Zhongguo Gu Shang; 2014 Jul; 27(7):609-14. PubMed ID: 25338452
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
Joice M; Vasileiadis GI; Amanatullah DF
Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
[TBL] [Abstract][Full Text] [Related]
6. Selective versus non-selective NSAIDs as prophylaxis for heterotopic ossification following hip arthroplasty: a meta-analysis.
Migliorini F; Pintore A; Baroncini A; Pastor T; Hildebrand F; Maffulli N
J Orthop Traumatol; 2022 Jul; 23(1):30. PubMed ID: 35809109
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis.
Shapira J; Yelton MJ; Chen JW; Rosinsky PJ; Maldonado DR; Meghpara M; Lall AC; Domb BG
Hip Int; 2022 Sep; 32(5):576-590. PubMed ID: 33736491
[TBL] [Abstract][Full Text] [Related]
8. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
Xue D; Zheng Q; Li H; Qian S; Zhang B; Pan Z
Int Orthop; 2011 Jan; 35(1):3-8. PubMed ID: 19830425
[TBL] [Abstract][Full Text] [Related]
9. Postoperative nonsteroidal antiinflammatory drugs and the prevention of heterotopic ossification after cervical arthroplasty: analysis using CT and a minimum 2-year follow-up.
Tu TH; Wu JC; Huang WC; Chang HK; Ko CC; Fay LY; Wu CL; Cheng H
J Neurosurg Spine; 2015 May; 22(5):447-53. PubMed ID: 25723121
[TBL] [Abstract][Full Text] [Related]
10. NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.
Migliorini F; Trivellas A; Eschweiler J; Driessen A; Tingart M; Maffulli N
Calcif Tissue Int; 2021 Feb; 108(2):196-206. PubMed ID: 33044630
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac for prophylaxis of heterotopic ossification after hip arthroplasty: a systematic review.
Haffer H; Müller M; Ascherl R; Perka C; Winkler T
Hip Int; 2022 Mar; 32(2):144-151. PubMed ID: 33272062
[TBL] [Abstract][Full Text] [Related]
12. Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery.
Rath E; Warschawski Y; Maman E; Dolkart O; Sharfman ZT; Salai M; Amar E
Am J Sports Med; 2016 Mar; 44(3):677-81. PubMed ID: 26695395
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2004; (3):CD001160. PubMed ID: 15266441
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.
Pakos EE; Ioannidis JP
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):888-95. PubMed ID: 15465207
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Fransen M; Neal B
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD001160. PubMed ID: 23543510
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty.
Neal B; Rodgers A; Dunn L; Fransen M
Cochrane Database Syst Rev; 2000; (3):CD001160. PubMed ID: 10908488
[TBL] [Abstract][Full Text] [Related]
17. The Effect of NSAID Prophylaxis and Operative Variables on Heterotopic Ossification After Hip Arthroscopy.
Beckmann JT; Wylie JD; Kapron AL; Hanson JA; Maak TG; Aoki SK
Am J Sports Med; 2014 Jun; 42(6):1359-64. PubMed ID: 24664136
[TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors for the prevention of heterotopic ossification after THA.
Vasileiadis GI; Sioutis IC; Mavrogenis AF; Vlasis K; Babis GC; Papagelopoulos PJ
Orthopedics; 2011 Jun; 34(6):467. PubMed ID: 21661680
[TBL] [Abstract][Full Text] [Related]
19. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
[TBL] [Abstract][Full Text] [Related]
20. Prevention of heterotopic ossification after total hip replacement with NSAIDs.
Fijn R; Koorevaar RT; Brouwers JR
Pharm World Sci; 2003 Aug; 25(4):138-45. PubMed ID: 12964491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
